93 related articles for article (PubMed ID: 17846226)
1. Phase 2 study of pegylated liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi sarcoma.
Little RF; Aleman K; Kumar P; Wyvill KM; Pluda JM; Read-Connole E; Wang V; Pittaluga S; Catanzaro AT; Steinberg SM; Yarchoan R
Blood; 2007 Dec; 110(13):4165-71. PubMed ID: 17846226
[TBL] [Abstract][Full Text] [Related]
2. Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma.
Little RF; Pluda JM; Wyvill KM; Rodriguez-Chavez IR; Tosato G; Catanzaro AT; Steinberg SM; Yarchoan R
Blood; 2006 Jun; 107(12):4650-7. PubMed ID: 16507779
[TBL] [Abstract][Full Text] [Related]
3. Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings.
Epeldegui M; Chang D; Lee J; Magpantay LI; Borok M; Bukuru A; Busakhala N; Godfrey C; Hosseinipour MC; Kang M; Kanyama C; Langat D; Mngqibisa R; Mwelase N; Nyirenda M; Samaneka W; Hoagland B; Campbell TB; Martínez-Maza O; Krown SE;
J Acquir Immune Defic Syndr; 2023 Oct; 94(2):165-173. PubMed ID: 37368929
[TBL] [Abstract][Full Text] [Related]
4. Clinical management of Kaposi sarcoma herpesvirus-associated diseases: an update on disease manifestations and treatment strategies.
Patel R; Lurain K; Yarchoan R; Ramaswami R
Expert Rev Anti Infect Ther; 2023; 21(9):929-941. PubMed ID: 37578202
[TBL] [Abstract][Full Text] [Related]
5. IL12 immune therapy clinical trial review: Novel strategies for avoiding CRS-associated cytokines.
Jia Z; Ragoonanan D; Mahadeo KM; Gill J; Gorlick R; Shpal E; Li S
Front Immunol; 2022; 13():952231. PubMed ID: 36203573
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy for KSHV-associated diseases.
Lurain K; Yarchoan R; Ramaswami R
Curr Opin Virol; 2022 Aug; 55():101249. PubMed ID: 35803203
[TBL] [Abstract][Full Text] [Related]
7. Nanodrugs Targeting T Cells in Tumor Therapy.
Haist M; Mailänder V; Bros M
Front Immunol; 2022; 13():912594. PubMed ID: 35693776
[TBL] [Abstract][Full Text] [Related]
8. Oncologic Treatment of HIV-Associated Kaposi Sarcoma 40 Years on.
Ramaswami R; Lurain K; Yarchoan R
J Clin Oncol; 2022 Jan; 40(3):294-306. PubMed ID: 34890242
[TBL] [Abstract][Full Text] [Related]
9. Metformin-conjugated micellar system with intratumoral pH responsive de-shielding for co-delivery of doxorubicin and nucleic acid.
Liu Y; Sun J; Huang Y; Chen Y; Li J; Liang L; Xu J; Wan Z; Zhang B; Li Z; Li S
Biochem Pharmacol; 2021 Jul; 189():114453. PubMed ID: 33545119
[TBL] [Abstract][Full Text] [Related]
10. Cytokine-Targeted Therapeutics for KSHV-Associated Disease.
Alomari N; Totonchy J
Viruses; 2020 Sep; 12(10):. PubMed ID: 32998419
[TBL] [Abstract][Full Text] [Related]
11. A Pilot Study of Liposomal Doxorubicin Combined with Bevacizumab followed by Bevacizumab Monotherapy in Patients with Advanced Kaposi Sarcoma.
Ramaswami R; Uldrick TS; Polizzotto MN; Wyvill KM; Goncalves P; Widell A; Lurain K; Steinberg SM; Figg WD; Tosato G; Whitby D; Yarchoan R
Clin Cancer Res; 2019 Jul; 25(14):4238-4247. PubMed ID: 30979736
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients.
Adriaensen W; Dorlo TPC; Vanham G; Kestens L; Kaye PM; van Griensven J
Front Immunol; 2017; 8():1943. PubMed ID: 29375567
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 12 shows a better curative effect on lung cancer than paclitaxel and cisplatin doublet chemotherapy.
Yue T; Zheng X; Dou Y; Zheng X; Sun R; Tian Z; Wei H
BMC Cancer; 2016 Aug; 16(1):665. PubMed ID: 27549240
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 12: still a promising candidate for tumor immunotherapy?
Lasek W; Zagożdżon R; Jakobisiak M
Cancer Immunol Immunother; 2014 May; 63(5):419-35. PubMed ID: 24514955
[TBL] [Abstract][Full Text] [Related]
15. Advances in the systemic treatment of cutaneous sarcomas.
Luke JJ; Keohan ML
Semin Oncol; 2012 Apr; 39(2):173-83. PubMed ID: 22484189
[TBL] [Abstract][Full Text] [Related]
16. HemaMax™, a recombinant human interleukin-12, is a potent mitigator of acute radiation injury in mice and non-human primates.
Basile LA; Ellefson D; Gluzman-Poltorak Z; Junes-Gill K; Mar V; Mendonca S; Miller JD; Tom J; Trinh A; Gallaher TK
PLoS One; 2012; 7(2):e30434. PubMed ID: 22383962
[TBL] [Abstract][Full Text] [Related]
17. Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.
Uldrick TS; Whitby D
Cancer Lett; 2011 Jun; 305(2):150-62. PubMed ID: 21377267
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi's sarcoma.
Cainelli F; Vallone A
Biologics; 2009; 3():385-90. PubMed ID: 19774206
[TBL] [Abstract][Full Text] [Related]
19. Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis.
Wen KW; Damania B
Cancer Lett; 2010 Mar; 289(2):140-50. PubMed ID: 19651473
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
